1. Prioritize reliable clinical information
For eye-health topics, we prioritize relevant resources from the National Eye Institute, ophthalmology professional organizations, peer-reviewed research, and responsible regulatory authorities. A mechanistic theory or manufacturer summary is not equivalent to a clinical trial.
2. Match the claim to the population
AREDS2 research focuses on particular AMD stages. It does not establish that supplements restore vision in all older adults. We aim to state who was studied and which outcome improved.
3. Separate ingredients from finished products
When evidence concerns an isolated nutrient or a specific studied formula, we do not automatically attribute that outcome to an unrelated proprietary blend. Ingredient doses and label transparency are explicit comparison criteria.
4. Do not invent first-hand experience
We will not claim to have tested, purchased, interviewed users of, or personally reviewed a supplement without real evidence of that work. We distinguish label research from hands-on product testing and avoid manufactured star ratings.
5. Identify commercial relationships
Future affiliate links will be identified near recommendations, and qualifying links will use rel="sponsored". Paid relationships must not influence statements about efficacy or medical risk.
6. Require editorial and clinical sign-off for health claims
Medical claims should be fact-checked against authoritative evidence and, where practical, reviewed by an appropriately qualified professional before publishing. Do not display a named reviewer or degree without a real verification process.
7. Update only when something changes
A new updated date should reflect substantive rechecking of evidence, labels, links or editorial content. Prior versions and major corrections should be documented internally rather than quietly changing the conclusion.
8. Handle corrections transparently
Send source links and the relevant passage through the contact page. We review documented corrections and update affected articles where justified. Site ownership and the operational correction workflow must be verified before public launch.
9. Avoid manipulative cross-site linking
Related publications under overlapping ownership may be referenced only where a specific article adds genuine independent informational value. Shared ownership must not be concealed to imply an independent endorsement. We do not add sitewide reciprocal backlinks or create content just to pass ranking signals.
Working-stage limitation
This Phase 3 Astro rebuild contains editorial drafts that require final fact-checking, review of current product labels where applicable, and approval by the real publisher before production deployment.